Vivos Therapeutics, Inc. (VVOS) SEC filings
VVOS SEC filings moved a median of -1.62% by the close. VVOS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VVOS overview →
94 measured VVOS SEC filing events.
Where these VVOS SEC filings landedvs 93 measured VVOS SEC filing reactions
| Middle 50% of VVOS SEC filing reactions | -6.70% to +2.35% |
|---|---|
| Median reaction (to close) | -1.62% |
| Measured reactions | 93 |
Point-in-time · zero look-ahead
Half of the 93 VVOS SEC filing events with a measured close landed between -6.70% and +2.35%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Vivos Therapeutics, Inc. For: Oct 15 | SEC filing · Form 8-K | -2.60% | +7.58% | |
| Form PRE 14A Vivos Therapeutics, Inc. For: Oct 19 | SEC filing · Form PRE | -2.60% | +7.58% | |
| Form 8-K Vivos Therapeutics, Inc. For: Oct 14 | SEC filing · Form 8-K | -3.67% | +5.93% | |
| Form 8-K Vivos Therapeutics, Inc. For: Sep 29 | SEC filing · Form 8-K | +0.69% | +3.47% | |
| Form 8-K Vivos Therapeutics, Inc. For: Aug 31 | SEC filing · Form 8-K | +2.31% | -1.37% | |
| Form 8-K/A Vivos Therapeutics, Inc. For: Sep 02 | SEC filing · Form 8-K | +0.60% | +1.61% | |
| Form 8-K Vivos Therapeutics, Inc. For: Aug 20 | SEC filing · Form 8-K | -5.60% | -7.73% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +6.31% | +0.07% | |
| Form 8-K Vivos Therapeutics, Inc. For: Aug 05 | SEC filing · Form 8-K | -4.47% | -7.32% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jul 31 | SEC filing · Form 8-K | -0.38% | +8.75% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jul 07 | SEC filing · Form 8-K | -2.71% | +3.31% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jun 25 | SEC filing · Form 8-K | +0.00% | +3.85% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jun 15 | SEC filing · Form 8-K | -0.09% | -3.80% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jun 16 | SEC filing · Form 8-K | +2.28% | -3.55% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jun 08 | SEC filing · Form 8-K | -1.52% | +6.10% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.37% | +0.83% | |
| Form NT 10-Q Vivos Therapeutics, Inc. For: Mar 31 | SEC filing · Form NT | -1.57% | -6.70% | |
| Form EFFECT Vivos Therapeutics, Inc. | SEC filing · Form EFFECT | +1.00% | -0.06% | |
| Form S-3/A Vivos Therapeutics, Inc. | SEC filing · Form S-3 | +2.18% | +0.33% | |
| Form 8-K Vivos Therapeutics, Inc. For: Apr 22 | SEC filing · Form 8-K | -4.76% | -14.68% | |
| Form 10-K Vivos Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.42% | -12.10% | |
| Form 8-K Vivos Therapeutics, Inc. For: Apr 15 | SEC filing · Form 8-K | +2.42% | -12.10% | |
| Form 8-K Vivos Therapeutics, Inc. For: Apr 03 | SEC filing · Form 8-K | -1.43% | -6.43% | |
| Form NT 10-K Vivos Therapeutics, Inc. For: Dec 31 | SEC filing · Form NT | -1.71% | +11.11% | |
| Form S-3 Vivos Therapeutics, Inc. | SEC filing · Form S-3 | -1.33% | +5.33% | |
| Form 8-K Vivos Therapeutics, Inc. For: Feb 06 | SEC filing · Form 8-K | +2.05% | +10.46% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jan 20 | SEC filing · Form 8-K | +0.00% | -7.11% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jan 16 | SEC filing · Form 8-K | -0.97% | -4.83% | |
| Form EFFECT Vivos Therapeutics, Inc. | SEC filing · Form EFFECT | -3.07% | -2.63% | |
| Form POS AM Vivos Therapeutics, Inc. | SEC filing · Form POS | -0.99% | -2.37% | |
| Form 8-K Vivos Therapeutics, Inc. For: Dec 16 | SEC filing · Form 8-K | -1.46% | -5.34% | |
| Form 8-K Vivos Therapeutics, Inc. For: Dec 05 | SEC filing · Form 8-K | +0.00% | +2.86% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.54% | -6.20% | |
| Form 8-K Vivos Therapeutics, Inc. For: Nov 19 | SEC filing · Form 8-K | +3.54% | -6.20% | |
| Form NT 10-Q Vivos Therapeutics, Inc. For: Sep 30 | SEC filing · Form NT | -0.84% | +0.00% | |
| Form 8-K Vivos Therapeutics, Inc. For: Nov 04 | SEC filing · Form 8-K | +0.00% | +2.97% | |
| Form 8-K Vivos Therapeutics, Inc. For: Oct 24 | SEC filing · Form 8-K | -4.66% | -10.82% | |
| Form DEF 14A Vivos Therapeutics, Inc. For: Sep 26 | SEC filing · Form DEF | +0.64% | +0.32% | |
| Form 8-K Vivos Therapeutics, Inc. For: Sep 17 | SEC filing · Form 8-K | -2.28% | -4.84% | |
| Form 8-K Vivos Therapeutics, Inc. For: Sep 12 | SEC filing · Form 8-K | -3.10% | -4.79% | |
| Form EFFECT Vivos Therapeutics, Inc. | SEC filing · Form EFFECT | -1.62% | -1.62% | |
| Form S-3/A Vivos Therapeutics, Inc. | SEC filing · Form S-3 | -2.68% | -6.81% | |
| Form 8-K/A Vivos Therapeutics, Inc. For: Jun 09 | SEC filing · Form 8-K | +1.08% | +1.08% | |
| Form 8-K Vivos Therapeutics, Inc. For: Aug 20 | SEC filing · Form 8-K | -1.20% | +10.58% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.07% | — | |
| Form NT 10-Q Vivos Therapeutics, Inc. For: Jun 30 | SEC filing · Form NT | -6.92% | -5.08% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jun 13 | SEC filing · Form 8-K | -0.93% | +3.72% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jun 06 | SEC filing · Form 8-K | +1.42% | +0.94% | |
| Form 8-K Vivos Therapeutics, Inc. For: May 23 | SEC filing · Form 8-K | +1.43% | +8.57% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.72% | -12.41% | |
| Form 8-K Vivos Therapeutics, Inc. For: May 15 | SEC filing · Form 8-K | -1.72% | -12.41% | |
| Form 8-K Vivos Therapeutics, Inc. For: Apr 17 | SEC filing · Form 8-K | -1.44% | +0.48% | |
| Form 10-K Vivos Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.48% | -6.74% | |
| Form 8-K Vivos Therapeutics, Inc. For: Mar 31 | SEC filing · Form 8-K | +2.48% | -6.74% | |
| Form 8-K Vivos Therapeutics, Inc. For: Feb 14 | SEC filing · Form 8-K | +3.19% | +1.27% | |
| Form S-3 Vivos Therapeutics, Inc. | SEC filing · Form S-3 | -0.52% | +0.52% | |
| Form EFFECT Vivos Therapeutics, Inc. | SEC filing · Form EFFECT | -0.25% | +0.51% | |
| Form S-1/A Vivos Therapeutics, Inc. | SEC filing · Form S-1 | +0.00% | +2.66% | |
| Form S-1 Vivos Therapeutics, Inc. | SEC filing · Form S-1 | +0.00% | -6.85% | |
| Form 8-K Vivos Therapeutics, Inc. For: Dec 23 | SEC filing · Form 8-K | -5.44% | -6.60% | |
| Form 8-K Vivos Therapeutics, Inc. For: Nov 27 | SEC filing · Form 8-K | +0.74% | +0.59% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.13% | -9.84% | |
| Form 8-K Vivos Therapeutics, Inc. For: Nov 14 | SEC filing · Form 8-K | -4.13% | -9.84% | |
| Form DEFA14A Vivos Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.00% | +3.65% | |
| Form DEF 14A Vivos Therapeutics, Inc. For: Oct 07 | SEC filing · Form DEF | +0.83% | +0.00% | |
| Form 8-K Vivos Therapeutics, Inc. For: Sep 20 | SEC filing · Form 8-K | -0.63% | -3.15% | |
| Form 8-K Vivos Therapeutics, Inc. For: Sep 18 | SEC filing · Form 8-K | -8.50% | +21.11% | |
| Form 8-K Vivos Therapeutics, Inc. For: Sep 17 | SEC filing · Form 8-K | -8.50% | +21.11% | |
| Form 8-K Vivos Therapeutics, Inc. For: Sep 12 | SEC filing · Form 8-K | -0.89% | +1.38% | |
| Form 8-K Vivos Therapeutics, Inc. For: Aug 14 | SEC filing · Form 8-K | — | -15.46% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | -15.46% | |
| Form EFFECT Vivos Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | -2.47% | |
| Form 10-K/A Vivos Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.29% | -6.03% | |
| Form S-3 Vivos Therapeutics, Inc. | SEC filing · Form S-3 | +1.29% | -6.03% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jul 10 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jun 25 | SEC filing · Form 8-K | -1.60% | -0.46% | |
| Form 8-K Vivos Therapeutics, Inc. For: Jun 14 | SEC filing · Form 8-K | +0.00% | -10.09% | |
| Form 8-K Vivos Therapeutics, Inc. For: May 17 | SEC filing · Form 8-K | +0.00% | -0.44% | |
| Form 8-K Vivos Therapeutics, Inc. For: May 15 | SEC filing · Form 8-K | +1.35% | +1.83% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.70% | +2.35% | |
| Form 8-K Vivos Therapeutics, Inc. For: May 03 | SEC filing · Form 8-K | -2.50% | -10.53% | |
| Form EFFECT Vivos Therapeutics, Inc. | SEC filing · Form EFFECT | -3.55% | +2.37% | |
| Form S-1/A Vivos Therapeutics, Inc. | SEC filing · Form S-1 | -0.76% | -0.38% | |
| Form S-1 Vivos Therapeutics, Inc. | SEC filing · Form S-1 | +5.30% | -8.78% | |
| Form 8-K Vivos Therapeutics, Inc. For: Mar 28 | SEC filing · Form 8-K | +0.67% | -10.13% | |
| Form 10-K Vivos Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.67% | -10.13% | |
| Form 8-K Vivos Therapeutics, Inc. For: Feb 15 | SEC filing · Form 8-K | +0.20% | +6.99% | |
| Form EFFECT Vivos Therapeutics, Inc. | SEC filing · Form EFFECT | -2.24% | -7.05% | |
| Form 8-K Vivos Therapeutics, Inc. For: Nov 30 | SEC filing · Form 8-K | -7.85% | -3.58% | |
| Form S-1/A Vivos Therapeutics, Inc. | SEC filing · Form S-1 | -7.85% | -3.58% | |
| Form S-1 Vivos Therapeutics, Inc. | SEC filing · Form S-1 | -0.25% | +12.25% | |
| Form 10-Q Vivos Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.06% | -2.53% | |
| Form 8-K Vivos Therapeutics, Inc. For: Nov 02 | SEC filing · Form 8-K | +0.00% | -1.72% | |
| Form 8-K Vivos Therapeutics, Inc. For: Oct 27 | SEC filing · Form 8-K | -0.49% | -6.13% |
Keep exploring
More VVOS: earnings → · analyst actions → · VVOS overview →